Botulinum antitoxins and antibacterial IgM and IgG antibodies in sera of persons immunized with botulinum polytoxoid combined with cholera vaccine. I. Response to botulinum toxoid.
Two groups of subjects were immunized with combined vaccine containing aluminum hydroxide-adsorbed botulinum toxoids, types A, B, and E, and 4 mld of formaldehyde-inactivated V. cholerae Inaba and Ogawa organisms. The first group included laboratory workers who were previously immunized against cholera and had professional contact with botulinum toxins and viable V. cholerae organisms. The second group included young men who were never vaccinated against botulism or cholera. The three-dose immunization schedule with combined vaccine resulted in clear-cut antitoxin response; after the third dose, the A, B, and E antitoxin level ranged from 0-2 to 10 IU/ml. Immunity against botulinum toxins lasted at least one year. Distribution of the antitoxins among IgM and IgG globulin classes resembled that in the case of response to other toxoids; 21 days after the third immunization antitoxin activity was found in IgG globulins.
D000328:Adult; D000907:Antibodies, Bacterial / Q000096:biosynthesis*; D001904:Botulinum Antitoxin / Q000032:analysis*; D001906:Botulism / Q000517:prevention & control*; D022121:Cholera Vaccines / Q000627:therapeutic use*; D003014:Clostridium botulinum / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis*; D007075:Immunoglobulin M / Q000096:biosynthesis*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014121:Toxoids / Q000008:administration & dosage*
D000907:Antibodies, Bacterial; D001904:Botulinum Antitoxin; D022121:Cholera Vaccines; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D014121:Toxoids